Genome-wide association study in breast cancer survivors reveals SNPs associated with gene expression of genes belonging to MHC class I and II

Genomics

Volumn 102, Issue 4, 2013, Pages 278-287

  Landmark Høyvik, Hege ^a,b   Dumeaux, Vanessa ^c   Nebdal, Daniel ^a   Lund, Eiliv ^c   Tost, Jörg ^d,e   Kamatani, Yoichiro ^e   Renault, Victor ^e   Børresen Dale, Anne Lise ^a,b   Kristensen, Vessela ^a,b,f   Edvardsen, Hege ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d DIF   (France)

^e FONDATION JEAN DAUSSET CEPH   (France)

^f AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast cancer; Breast cancer survivors; EQTL; Gene expression; Radiotherapy; SNP; Treatment

Indexed keywords

HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB3 ANTIGEN; HLA DRB4 ANTIGEN; HLA E ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER SURVIVOR; CHROMOSOME 6; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC VARIABILITY; HLA C GENE; HLA DPB1 GENE; HLA DQA1 GENE; HLA DQB1 GENE; HLA DRB3 GENE; HLA DRB4 GENE; HLA E GENE; HLA F GENE; HLA G GENE; HLA H GENE; HUMAN; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PSEUDOGENE; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR IMMUNITY;

BC; BREAST CANCER; BREAST CANCER SURVIVORS; CHR; CHROMOSOME; EQTL; FALSE DISCOVERY RATE; FDR; GENE EXPRESSION; HLA; HUMAN LEUKOCYTE ANTIGEN; INGENUITY PATHWAY ANALYSIS; IPA; LD; LINKAGE DISEQUILIBRIUM; MAJOR HISTOCOMPATIBILITY; MESSENGER RNA; MHC; MRNA; RADIOTHERAPY; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; TREATMENT; UNTRANSLATED REGION; UTR;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; COHORT STUDIES; FEMALE; GENE EXPRESSION; GENES, MHC CLASS I; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINEAR MODELS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVIVORS;

EID: 84886245759     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2013.07.006     Document Type: Article

References (33)

1. Cancer Registry of Norway. Cancer in Norway 2008 - Cancer incidence, mortality, survival and prevalence in Norway. 2009.
2. Bentzen S.M. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat. Rev. Cancer 2006, 6:702-713.
3. Andrykowski M.A., Curran S.L., Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J. Behav. Med. 1998, 21:1-18.
4. Broeckel J.A., Jacobsen P.B., Horton J., Balducci L., Lyman G.H. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 1998, 16:1689-1696.
5. Yabroff K.R., Lawrence W.F., Clauser S., Davis W.W., Brown M.L. Burden of illness in cancer survivors: findings from a population-based national sample. J. Natl. Cancer Inst. 2004, 96:1322-1330.
6. Landmark-Hoyvik H., Reinertsen K.V., Loge J.H., Fossa S.D., Borresen-Dale A.L., Dumeaux V. Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics J. 2009, 9:333-340.
7. Landmark-Hoyvik H., Dumeaux V., Reinertsen K.V., Edvardsen H., Fossa S.D., Borresen-Dale A.L. Blood gene expression profiling of breast cancer survivors experiencing fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 2011, 79:875-883.
8. Bower J.E., Ganz P.A., Irwin M.R., Arevalo J.M., Cole S.W. Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav. Immun. 2011, 25:147-150.
9. Stranger B.E., Forrest M.S., Clark A.G., Minichiello M.J., Deutsch S., Lyle R., et al. Genome-wide associations of gene expression variation in humans. PLoS Genet. 2005, 1:e78.
10. Schadt E.E., Monks S.A., Drake T.A., Lusis A.J., Che N., Colinayo V., et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 2003, 20(422):297-302.
11. Morley M., Molony C.M., Weber T.M., Devlin J.L., Ewens K.G., Spielman R.S., et al. Genetic analysis of genome-wide variation in human gene expression. Nature 2004, 430:743-747.
12. Cheung V.G., Spielman R.S., Ewens K.G., Weber T.M., Morley M., Burdick J.T. Mapping determinants of human gene expression by regional and genome-wide association. Nature 2005, 437:1365-1369.
13. Giotopoulos G., Symonds R.P., Foweraker K., Griffin M., Peat I., Osman A., et al. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br. J. Cancer 2007, 96:1001-1007.
14. Andreassen C.N., Alsner J., Overgaard M., Overgaard J. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother. Oncol. 2003, 69:127-135.
15. Collado-Hidalgo A., Bower J.E., Ganz P.A., Irwin M.R., Cole S.W. Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings. Brain Behav. Immun. 2008, 22:1197-1200.
16. Barnett G.C., Coles C.E., Burnet N.G., Pharoah P.D., Wilkinson J., West C.M., et al. No association between SNPs regulating TGF-beta1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study. Radiother. Oncol. 2010, 97:9-14.
17. Quarmby S., Fakhoury H., Levine E., Barber J., Wylie J., Hajeer A.H., et al. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int. J. Radiat. Biol. 2003, 79:137-143.
18. Andreassen C.N., Alsner J., Overgaard M., Sorensen F.B., Overgaard J. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM-a study based on DNA from formalin fixed paraffin embedded tissue samples. Int. J. Radiat. Biol. 2006, 82:577-586.
19. Nicolae D.L., Gamazon E., Zhang W., Duan S., Dolan M.E., Cox N.J. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 2010, 6:e1000888.
20. Bower J.E., Ganz P.A., Aziz N., Fahey J.L. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom. Med. 2002, 64:604-611.
21. Bower J.E. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav. Immun. 2007, 21:863-871.
22. Quigley D.A., To M.D., Kim I.J., Lin K.K., Albertson D.G., Sjolund J., et al. Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility. Genome Biol. 2011, 12:R5.
23. Horton R., Wilming L., Rand V., Lovering R.C., Bruford E.A., Khodiyar V.K., et al. Gene map of the extended human MHC. Nat. Rev. Genet. 2004, 5:889-899.
24. Dixon A.L., Liang L., Moffatt M.F., Chen W., Heath S., Wong K.C., et al. A genome-wide association study of global gene expression. Nat. Genet. 2007, 39:1202-1207.
25. Handunnetthi L., Ramagopalan S.V., Ebers G.C., Knight J.C. Regulation of major histocompatibility complex class II gene expression, genetic variation and disease. Genes Immun. 2010, 11:99-112.
26. Whitney A.R., Diehn M., Popper S.J., Alizadeh A.A., Boldrick J.C., Relman D.A., et al. Individuality and variation in gene expression patterns in human blood. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1896-1901.
27. Spraggs C.F., Budde L.R., Briley L.P., Bing N., Cox C.J., King K.S., et al. HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. J. Clin. Oncol. 2011, 20(29):667-673.
28. Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 2007, 39:1329-1337.
29. Adamski J., Ma Z., Nozell S., Benveniste E.N. 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter. Mol. Endocrinol. 2004, 18:1963-1974.
30. Dumeaux V., Johansen J., Borresen-Dale A.L., Lund E. Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy. Mol. Cancer Ther. 2006, 5:868-876.
31. Mansmann U., Meister R. Testing differential gene expression in functional groups. Goeman's global test versus an ANCOVA approach. Methods Inf. Med. 2005, 44:449-453.
32. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., Bender D., et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am. J. Hum. Genet. 2007, 81:559-575.
33. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Ser. B 1995, 57:289-300.